Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain JNJ message board posts where the ticker symbol JNJ has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest JNJ SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0000200406-18-000039 (34 Act)  Size: 2 MB
2018-07-17 001-03215
18955491
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001225208-18-011617 Size: 14 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001225208-18-011616 Size: 17 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001225208-18-011615 Size: 19 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001225208-18-011614 Size: 19 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001225208-18-011613 Size: 21 KB
2018-07-11
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0000904454-18-000453 (34 Act)  Size: 6 KB
2018-07-03 001-38552
18938924
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000200406-18-000036 (34 Act)  Size: 365 KB
2018-06-28 001-03215
18926272
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000200406-18-000035 (34 Act)  Size: 359 KB
2018-06-28 001-03215
18926233
11-K  Documents Annual report of employee stock purchase, savings and similar plans
Acc-no: 0000200406-18-000034 (34 Act)  Size: 371 KB
2018-06-28 001-03215
18926206
More JNJ SEC Filings


Related news from
Fri, 20 Jul 2018
01:07:09 +0000
Women who sued Johnson & Johnson declare victory after $4.69 billion talc verdict
A woman who claimed her cancer was caused by using Johnson & Johnson's (JNJ.N) baby powder for decades said she believes justice was served after a jury found the company should pay her and 21 other women $4.69 billion in damages. A St. Louis jury on July 12 concluded that J&J's talc-based products contained asbestos, causing the 22 women, six of whom have died, to develop ovarian cancer. J&J Chief Executive Alex Gorsky earlier this week expressed confidence that the jury decision will be overturned on appeal.
Thu, 19 Jul 2018
18:58:06 +0000
Johnson & Johnson and General Motors: Growth and Income Stocks
This week I discuss two companies within the Income Investor portfolio; Johnson & Johnson (JNJ) and General Motors (GM).
Thu, 19 Jul 2018
18:46:48 +0000
Women who sued J&J declare victory after $4.69 bln talc verdict
A woman who claimed her cancer was caused by using Johnson & Johnson's baby powder for decades said she believes justice was served after a jury found the company should pay her and 21 other women $4.69 billion in damages. A St. Louis jury on July 12 concluded that J&J's talc-based products contained asbestos, causing the 22 women, six of whom have died, to develop ovarian cancer. J&J Chief Executive Alex Gorsky earlier this week expressed confidence that the jury decision will be overturned on appeal.
Thu, 19 Jul 2018
18:29:23 +0000
These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories
UnitedHealth delivered an earnings beat, but its shares fell. Johnson & Johnson's stock took a strong jump on earnings, despite recent bad news from a jury.
Thu, 19 Jul 2018
17:03:07 +0000
Edited Transcript of JNJ earnings conference call or presentation 17-Jul-18 12:30pm GMT
Q2 2018 Johnson & Johnson Earnings Call
Thu, 19 Jul 2018
14:14:00 +0000
AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short'
AbbVie Inc. (ABBV) shares dropped 5.5% in heavy Thursday morning trade after short seller Citron Research described the company as "the next great drug short" in a tweet and said it planned to release reports about the company. The Citron tweet came the day after Food and Drug Administration Commissioner Scott Gottlieb put out a plan to encourage the development and uptake of lower-priced biosimilar drugs, accusing large drugmakers in a speech of stymying the competition. The short seller also predicted that AbbVie shares, which closed at $94.40 on Wednesday, would drop to $60.
Thu, 19 Jul 2018
13:36:56 +0000
Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?
Wall Street's just dinged two of them and rewarded the third -- but Motley Fool analysts take a longer view.
Thu, 19 Jul 2018
11:34:00 +0000
Free Research Report as Johnson & Johnson's Quarterly Earnings Advanced 14.75%
LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want access to our free earnings report on Johnson & Johnson (NYSE: JNJ) ("JNJ”"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=JNJ. The Company reported its financial results on July 17, 2018, for the second quarter of the fiscal year 2018, ended June 30, 2018. The Company surpassed analysts’ estimates for earnings and revenues in Q2 FY18.
Thu, 19 Jul 2018
01:12:17 +0000
New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock
Celgene (NASDAQ:CELG) continues to struggle. A series of self-inflicted wounds and a looming patent expiration plague the Summit, New Jersey-based firm. As a result, CELG stock has lost more than 40% of its value since its October 2017 high.
Wed, 18 Jul 2018
21:57:09 +0000
J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod
The FDA approves Johnson and Johnson's (JNJ) darunavir-based single-tablet regimen, Symtuza, for the treatment of type 1 HIV-1 in treatment-naive and certain virologically suppressed adults.
Wed, 18 Jul 2018
14:05:02 +0000
Healthcare ETFs in Focus Following JNJ Q2 Results
Investors should closely watch the movement of the Johnson & Johnson and keep a close eye on ETFs having double-digit allocation to this diversified drug maker.
Wed, 18 Jul 2018
13:56:57 +0000
Penn, Johnson & Johnson team up to accelerate innovation
The university and health care giant are creating a life sciences network hub called JPOD@Philadelphia at the Pennovation Center.
Wed, 18 Jul 2018
13:53:01 +0000
Stock Market News For Jul 18, 2018
Markets closed sharply higher on Tuesday, led by a rally in tech stocks.
Wed, 18 Jul 2018
13:44:00 +0000
Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson shares.
Wed, 18 Jul 2018
12:42:30 +0000
Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling the Peaks (Stocks hitting 52-week highs on July 17) Avid Bioservices Inc (NASDAQ: CDMO )( reversed to a profit ...
Wed, 18 Jul 2018
12:10:00 +0000
Today's Research Reports on Stocks to Watch: Johnson & Johnson and Avid Bioservices
NEW YORK, NY / ACCESSWIRE / July 18, 2018 / Johnson & Johnson saw a pop after announcing second quarter results and vowing to appeal a court order last week that ordered the company to pay a whopping $4.69 billion to nearly two dozen women who alleged the company's talc products contained asbestos and caused them to develop ovarian cancer. Shares of Avid Bioservices also saw big gains after announcing a new CFO. Johnson & Johnson shares saw a gain of 3.54% by the close on Tuesday on trading volume nearly double compared to usual.
Wed, 18 Jul 2018
12:01:02 +0000
See what the IHS Markit Score report has to say about Johnson & Johnson.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting JNJ. Over the last one-month, outflows of investor capital in ETFs holding JNJ totaled $1.74 billion.
Wed, 18 Jul 2018
07:39:07 +0000
J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised)
A Missouri jury asked Johnson & Johnson (JNJ) to pay $4.69 billion in damages to 22 women and their families, who alleged that the company's baby powder contained asbestos that caused them to develop ovarian cancer.
Wed, 18 Jul 2018
03:41:08 +0000
Asian stocks rise as solid US performance lifts spirits
SINGAPORE (AP) — Asian markets climbed higher on Wednesday as a sweep of positive news from Wall Street and beyond boosted confidence in the U.S. economy.
Wed, 18 Jul 2018
02:49:04 +0000
[$$] Johnson & Johnson’s Pharma Business Fuels Sales Growth
Strong sales of Johnson & Johnson’s cancer drugs and other medicines helped boost the company’s revenue and earnings for the latest quarter, but the health-products giant’s U.S. consumer business continued to struggle. Sales in the pharmaceuticals unit rose 19.9% globally, the largest increase among J&J segments. Cancer-drug sales rose 42.2%, helped by big gains for the Zytiga prostate-cancer drug and Darzalex, a blood-cancer treatment. J&J’s pharmaceutical sales topped analysts’ expectations despite what executives said was a continued decline in average net U.S. pricing after discounts and rebates.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This is one of the brightest and most generous groups you will ever come across. While I firmly believe everyone has something to contribute to the collective wisdom, this is pretty much a left-brain group. Facts, evidence, and reasoned argument will earn you respect, even if some disagree with you." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards